XML 57 R36.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Selected Quarterly Financial Data (Unaudited) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract] |
Summary of Selected Quarterly Financial Data |
|  | 2013 |
|  | Q1 |  |  | Q2 |  |  | Q3 |  |  | Q4 |
|  | (In thousands, except per share data) |
Net patient revenues from continuing operations |  | $ | 61,432 |  |  | $ | 65,227 |  |  | $ | 64,368 |  |  | $ | 67,256 |
Net revenues from continuing operations |  | $ | 62,756 |  |  | $ | 66,868 |  |  | $ | 65,829 |  |  | $ | 68,605 |
Operating income from continuing operations |  | $ | 8,435 |  |  | $ | 11,059 |  |  | $ | 9,904 |  |  | $ | 9,372 |
Net income from continuing operations including noncontrolling interests |  | $ | 5,809 |  |  | $ | 7,642 |  |  | $ | 6,756 |  |  | $ | 5,796 |
Net income from continuing operations attributable to common shareholders |  | $ | 3,851 |  |  | $ | 5,079 |  |  | $ | 4,659 |  |  | $ | 3,903 |
Net losses from discontinued operations attributable to common shareholders |  | $ | (130 | ) |  | $ | (165 | ) |  | $ | (4,432 | ) |  | $ | (42 | )
Net income attributable to common shareholders. |  | $ | 3,721 |  |  | $ | 4,914 |  |  | $ | 227 |  |  | $ | 3,861 |
Basic earnings per share attributable to common shareholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
From continuing operations. |  | $ | 0.32 |  |  | $ | 0.42 |  |  | $ | 0.38 |  |  | $ | 0.32 |
From discontinued operations |  |  | (0.01 | ) |  |  | (0.01 | ) |  |  | (0.36 | ) |  |  | — |
Basic |  | $ | 0.31 |  |  | $ | 0.41 |  |  | $ | 0.02 |  |  | $ | 0.32 |
Diluted earnings per share attributable to common shareholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
From continuing operations. |  | $ | 0.32 |  |  | $ | 0.42 |  |  | $ | 0.38 |  |  | $ | 0.32 |
From discontinued operations |  |  | (0.01 | ) |  |  | (0.01 | ) |  |  | (0.36 | ) |  |  | — |
Diluted |  | $ | 0.31 |  |  | $ | 0.41 |  |  | $ | 0.02 |  |  | $ | 0.32 |
Shares used in computation: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic. |  |  | 11,955 |  |  |  | 12,089 |  |  |  | 12,106 |  |  |  | 12,103 |
Diluted |  |  | 11,979 |  |  |  | 12,110 |  |  |  | 12,120 |  |  |  | 12,117 |
|  | 2012 |
|  | Q1 |  |  | Q2 |  |  | Q3 |  |  | Q4 |
|  | (In thousands, except per share data) |
Net patient revenues from continuing operations |  | $ | 60,366 |  |  | $ | 61,963 |  |  | $ | 60,719 |  |  | $ | 61,052 |
Net revenues from continuing operations |  | $ | 61,771 |  |  | $ | 63,397 |  |  | $ | 62,102 |  |  | $ | 62,381 |
Operating income from continuing operations |  | $ | 9,765 |  |  | $ | 10,806 |  |  | $ | 9,534 |  |  | $ | 8,301 |
Net income from continuing operations including noncontrolling interests |  | $ | 6,733 |  |  | $ | 7,452 |  |  | $ | 6,423 |  |  | $ | 6,032 |
Net income from continuing operations attributable to common shareholders |  | $ | 4,436 |  |  | $ | 4,958 |  |  | $ | 4,588 |  |  | $ | 4,230 |
Net income (losses) from discontinued operations attributable to common shareholders |  | $ | 42 |  |  | $ | (109 | ) |  | $ | (25 | ) |  | $ | (187 | )
Net income attributable to common shareholders |  | $ | 4,478 |  |  | $ | 4,849 |  |  | $ | 4,563 |  |  | $ | 4,043 |
Basic earnings per share attributable to common shareholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
From continuing operations. |  | $ | 0.37 |  |  | $ | 0.41 |  |  | $ | 0.39 |  |  | $ | 0.35 |
From discontinued operations |  |  | — |  |  |  | (0.01 | ) |  |  | — |  |  |  | (0.02 | )
Basic |  | $ | 0.37 |  |  | $ | 0.40 |  |  | $ | 0.39 |  |  | $ | 0.33 |
Diluted earnings per share attributable to common shareholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
From continuing operations. |  | $ | 0.37 |  |  | $ | 0.41 |  |  | $ | 0.38 |  |  | $ | 0.35 |
From discontinued operations |  |  | — |  |  |  | (0.01 | ) |  |  | — |  |  |  | (0.02 | )
Diluted. |  | $ | 0.37 |  |  | $ | 0.40 |  |  | $ | 0.38 |  |  | $ | 0.33 |
Shares used in computation: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 11,955 |  |  |  | 12,089 |  |  |  | 12,106 |  |  |  | 12,103 |
Diluted. |  |  | 11,979 |  |  |  | 12,110 |  |  |  | 12,120 |  |  |  | 12,117 |

X
- Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the quarterly financial data in the annual financial statements. The disclosure includes financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income (loss) before extraordinary items and cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a)-(j) -URI http://asc.fasb.org/extlink&oid=25249566&loc=d3e1280-108306 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration